Issue 85, 2012

A covalently reactive group-modified peptide that specifically reacts with lysine16 in amyloid β

Abstract

Lys16 is present in the core region of the amyloid β (Aβ) self-assembly in Alzheimer's disease. Here we report that the P9-NCS peptide can covalently react with Lys16 and inhibit Aβ neurotoxic fibrillization. Moreover P9-NCS has high selectivity and it cannot react with amylin, insulin, fetal bovine serum, Q11 and MUC1 peptide.

Graphical abstract: A covalently reactive group-modified peptide that specifically reacts with lysine16 in amyloid β

Supplementary files

Article information

Article type
Communication
Submitted
19 Jul 2012
Accepted
02 Sep 2012
First published
03 Sep 2012

Chem. Commun., 2012,48, 10565-10567

A covalently reactive group-modified peptide that specifically reacts with lysine16 in amyloid β

J. Ma, L. Zhao, D. Zhao, Q. Liu, C. Liu, W. Wu, Y. Chen, Y. Zhao and Y. Li, Chem. Commun., 2012, 48, 10565 DOI: 10.1039/C2CC35178A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements